Literature DB >> 21514415

Osteopontin modulates inflammation, mucin production, and gene expression signatures after inhalation of asbestos in a murine model of fibrosis.

Tara Sabo-Attwood1, Maria E Ramos-Nino, Maria Eugenia-Ariza, Maximilian B Macpherson, Kelly J Butnor, Pamela C Vacek, Sean P McGee, Jessica C Clark, Chad Steele, Brooke T Mossman.   

Abstract

Inflammation and lung remodeling are hallmarks of asbestos-induced fibrosis, but the molecular mechanisms that control these events are unclear. Using laser capture microdissection (LCM) of distal bronchioles in a murine asbestos inhalation model, we show that osteopontin (OPN) is up-regulated by bronchiolar epithelial cells after chrysotile asbestos exposures. In contrast to OPN wild-type mice (OPN(+/+)) inhaling asbestos, OPN null mice (OPN(-/-)) exposed to asbestos showed less eosinophilia in bronchoalveolar lavage fluids, diminished lung inflammation, and decreased mucin production. Bronchoalveolar lavage fluid concentrations of inflammatory cytokines (IL-1β, IL-4, IL-6, IL-12 subunit p40, MIP1α, MIP1β, and eotaxin) also were significantly less in asbestos-exposed OPN(-/-) mice. Microarrays performed on lung tissues from asbestos-exposed OPN(+/+) and OPN(-/-) mice showed that OPN modulated the expression of a number of genes (Col1a2, Timp1, Tnc, Eln, and Col3a1) linked to fibrosis via initiation and cross talk between IL-1β and epidermal growth factor receptor-related signaling pathways. Novel targets of OPN identified include genes involved in cell signaling, immune system/defense, extracellular matrix remodeling, and cell cycle regulation. Although it is unclear whether the present findings are specific to chrysotile asbestos or would be observed after inhalation of other fibers in general, these results highlight new potential mechanisms and therapeutic targets for asbestosis and other diseases (asthma, smoking-related interstitial lung diseases) linked to OPN overexpression.
Copyright © 2011 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21514415      PMCID: PMC3081197          DOI: 10.1016/j.ajpath.2011.01.048

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  56 in total

1.  Role of osteopontin in the pathogenesis of bleomycin-induced pulmonary fibrosis.

Authors:  F Takahashi; K Takahashi; T Okazaki; K Maeda; H Ienaga; M Maeda; S Kon; T Uede; Y Fukuchi
Journal:  Am J Respir Cell Mol Biol       Date:  2001-03       Impact factor: 6.914

Review 2.  Osteopontin: a key cytokine in cell-mediated and granulomatous inflammation.

Authors:  A O'Regan; J S Berman
Journal:  Int J Exp Pathol       Date:  2000-12       Impact factor: 1.925

3.  Increased phosphorylated extracellular signal-regulated kinase immunoreactivity associated with proliferative and morphologic lung alterations after chrysotile asbestos inhalation in mice.

Authors:  R F Robledo; S A Buder-Hoffmann; A B Cummins; E S Walsh; D J Taatjes; B T Mossman
Journal:  Am J Pathol       Date:  2000-04       Impact factor: 4.307

Review 4.  Role of oxidative stress in pulmonary fibrosis.

Authors:  C Mastruzzo; N Crimi; C Vancheri
Journal:  Monaldi Arch Chest Dis       Date:  2002 Jun-Aug

5.  Role of mitogen-activated protein kinases (MAPK) in cell injury and proliferation by environmental particulates.

Authors:  Maria E Ramos-Nino; Astrid Haegens; Arti Shukla; Brooke T Mossman
Journal:  Mol Cell Biochem       Date:  2002 May-Jun       Impact factor: 3.396

6.  Dual roles of IL-4 in lung injury and fibrosis.

Authors:  François Huaux; Tianju Liu; Bridget McGarry; Matt Ullenbruch; Sem H Phan
Journal:  J Immunol       Date:  2003-02-15       Impact factor: 5.422

7.  Osteopontin transcription in aortic vascular smooth muscle cells is controlled by glucose-regulated upstream stimulatory factor and activator protein-1 activities.

Authors:  Miri Bidder; Jian-Su Shao; Nichole Charlton-Kachigian; Arleen P Loewy; Clay F Semenkovich; Dwight A Towler
Journal:  J Biol Chem       Date:  2002-08-27       Impact factor: 5.157

Review 8.  Asbestos, lung cancers, and mesotheliomas: from molecular approaches to targeting tumor survival pathways.

Authors:  Nicholas H Heintz; Yvonne M W Janssen-Heininger; Brooke T Mossman
Journal:  Am J Respir Cell Mol Biol       Date:  2010-02       Impact factor: 6.914

9.  A mutant epidermal growth factor receptor targeted to lung epithelium inhibits asbestos-induced proliferation and proto-oncogene expression.

Authors:  Christopher B Manning; Andrew B Cummins; Michael W Jung; Ingrid Berlanger; Cynthia R Timblin; Cathy Palmer; Douglas J Taatjes; David Hemenway; Pamela Vacek; Brooke T Mossman
Journal:  Cancer Res       Date:  2002-08-01       Impact factor: 12.701

10.  A profibrotic function of IL-12p40 in experimental pulmonary fibrosis.

Authors:  Francois Huaux; Mohammed Arras; David Tomasi; Virginie Barbarin; Monique Delos; Jean-Paul Coutelier; Anne Vink; Sem H Phan; Jean-Christophe Renauld; Dominique Lison
Journal:  J Immunol       Date:  2002-09-01       Impact factor: 5.422

View more
  23 in total

Review 1.  The immunopathology of lung fibrosis: amphiregulin-producing pathogenic memory T helper-2 cells control the airway fibrotic responses by inducing eosinophils to secrete osteopontin.

Authors:  Kiyoshi Hirahara; Ami Aoki; Yuki Morimoto; Masahiro Kiuchi; Mikiko Okano; Toshinori Nakayama
Journal:  Semin Immunopathol       Date:  2019-04-09       Impact factor: 9.623

2.  Molecular insights into the progression of crystalline silica-induced pulmonary toxicity in rats.

Authors:  Rajendran Sellamuthu; Christina Umbright; Jenny R Roberts; Amy Cumpston; Walter McKinney; Bean T Chen; David Frazer; Shengqiao Li; Michael Kashon; Pius Joseph
Journal:  J Appl Toxicol       Date:  2012-03-19       Impact factor: 3.446

3.  Saturated fatty acids bound to albumin enhance osteopontin expression and cleavage in renal proximal tubular cells.

Authors:  Alyssa Cobbs; Kristopher Ballou; Xiaoming Chen; Jasmine George; Xueying Zhao
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2018-03-10

4.  The osteopontin transgenic mouse is a new model for Sjögren's syndrome.

Authors:  Sehba Husain-Krautter; Jill M Kramer; Wentian Li; Benchang Guo; Thomas L Rothstein
Journal:  Clin Immunol       Date:  2015-01-05       Impact factor: 3.969

5.  Short-Term Pulmonary Toxicity Assessment of Pre- and Post-incinerated Organomodified Nanoclay in Mice.

Authors:  Todd A Stueckle; Donna C Davidson; Ray Derk; Tiffany G Kornberg; Lori Battelli; Sherri Friend; Marlene Orandle; Alixandra Wagner; Cerasela Zoica Dinu; Konstantinos A Sierros; Sushant Agarwal; Rakesh K Gupta; Yon Rojanasakul; Dale W Porter; Liying Rojanasakul
Journal:  ACS Nano       Date:  2018-02-22       Impact factor: 15.881

6.  Human and experimental evidence supporting a role for osteopontin in alcoholic hepatitis.

Authors:  Oriol Morales-Ibanez; Marlene Domínguez; Sung H Ki; Miguel Marcos; Javier F Chaves; Eric Nguyen-Khac; Hakim Houchi; Silvia Affò; Pau Sancho-Bru; José Altamirano; Javier Michelena; Juan Carlos García-Pagán; Juan G Abraldes; Vicente Arroyo; Juan Caballería; Francisco-Javier Laso; Bin Gao; Ramón Bataller
Journal:  Hepatology       Date:  2013-08-19       Impact factor: 17.425

7.  Endogenous osteopontin promotes ozone-induced neutrophil recruitment to the lungs and airway hyperresponsiveness to methacholine.

Authors:  Ramon X Barreno; Jeremy B Richards; Daniel J Schneider; Kevin R Cromar; Arthur J Nadas; Christopher B Hernandez; Lance M Hallberg; Roger E Price; Syed S Hashmi; Michael R Blackburn; Ikram U Haque; Richard A Johnston
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-05-10       Impact factor: 5.464

8.  Osteopontin and other regulators of angiogenesis and fibrogenesis in the vitreous from patients with proliferative vitreoretinal disorders.

Authors:  Ahmed M Abu El-Asrar; Mohd Imtiaz Nawaz; Dustan Kangave; Mohammed Mairaj Siddiquei; Karel Geboes
Journal:  Mediators Inflamm       Date:  2012-09-29       Impact factor: 4.711

9.  Differential effects of simvastatin on IL-13-induced cytokine gene expression in primary mouse tracheal epithelial cells.

Authors:  Amir A Zeki; Phil Thai; Nicholas J Kenyon; Reen Wu
Journal:  Respir Res       Date:  2012-05-14

10.  Osteopontin is a novel downstream target of SOX9 with diagnostic implications for progression of liver fibrosis in humans.

Authors:  James Pritchett; Emma Harvey; Varinder Athwal; Andrew Berry; Cliff Rowe; Fiona Oakley; Anna Moles; Derek A Mann; Nicoletta Bobola; Andrew D Sharrocks; Brian J Thomson; Abed M Zaitoun; William L Irving; Indra N Guha; Neil A Hanley; Karen Piper Hanley
Journal:  Hepatology       Date:  2012-09       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.